Aspire Biopharma Holdings, Inc. (ASBPW) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 7.12M | 1.31M | 2.4M | 989.42K | 1.97M | 147.99K | 61.81K | 342.97K | 65.58K | 81.22K | 253.36K | 546.14K | 906.46K | 1.1M | 1.15M | 1.21M | 1.26M | 293.22K | 0 | 0 |
| Cash & Short-Term Investments | 5.86M | 1M | 1.95M | 206.23K | 1.35M | 3.63K | 6.6M | 19.6K | 0 | 0 | 280 | 125.2K | 315.15K | 497.26K | 533.13K | 579.75K | 618.12K | 0 | 0 | 0 |
| Cash Only | 5.86M | 1M | 1.95M | 206.23K | 1.35M | 3.63K | 6.6M | 0 | 0 | 0 | 280 | 125.2K | 315.15K | 497.26K | 533.13K | 579.75K | 618.12K | 0 | 0 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 36.5K | 25.03K | 299.92K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 369.97K | 253.16K | 35.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 1.24K | 2.52K | 3.08K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 890.15K | 0 | 0 | 0 | 0 | -36.5K | -6.73M | 23.45K | 65.58K | 81.22K | 253.08K | 420.94K | 591.3K | 600.49K | 613.36K | 629.13K | 644.9K | 293.22K | 0 | 0 |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 6.67M | 6.6M | 6.52M | 20.14M | 19.9M | 19.64M | 20.02M | 302.2M | 299.08M | 296.69M | 295.51M | 295.24M | 293.22K | 225.75K | 58.76K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.01M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 6.67M | 6.6M | 6.52M | 20.14M | 19.9M | 19.64M | 20.02M | 302.2M | 299M | 296.46M | 295.13M | 294.71T | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | -5.03M | -5.01M | 0 | 0 | 0 | 0 | 0 | 80.17K | 230.85K | 381.47K | -294.71T | 293.22K | 225.75K | 58.76K |
| Total Assets | 7.12M | 1.31M | 2.4M | 989.42K | 1.97M | 147.99K | 6.66M | 6.87M | 20.2M | 19.98M | 19.89M | 20.56M | 303.11M | 300.18M | 297.84M | 296.72M | 296.5M | 293.22K | 225.75K | 58.76K |
| Asset Turnover | 0.01x | 0.00x | 0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 262.1% | 786.66% | -63.93% | -85.59% | -90.27% | -99.26% | -66.51% | -66.6% | -93.34% | -93.34% | -93.32% | -93.07% | 2.23% | 102273.98% | 131831.74% | 504908.56% | 511349.08% | - | - | - |
| Total Current Liabilities | 3.15M | 7.59M | 13.86M | 10.56M | 8.87M | 1.69M | 6.57M | 6.24M | 2.63M | 403.33K | 316.32K | 284.36K | 356.42K | 303.32K | 188.71K | 146.47K | 51.76K | 293.7K | 225.47K | 43.16K |
| Accounts Payable | 857.92K | 1.01M | 1.06M | 1.35M | 1.43M | 310.22K | 903.69K | 584.08K | 365.01K | 152K | 104.38K | 101.67K | 203.73K | 180.63K | 96.02K | 83.78K | 19.07K | 273 | 0 | 0 |
| Days Payables Outstanding | 3.73K | 18.15K | 104.99K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 499.21K | 1.38M | 1.38M | 1.83M | 1.71M | 1.27M | 436.28K | 5.36M | 2M | 12.38K | 0 | 0 | 0 | 27.97K | 0 | 0 | 0 | 238.6K | 212.73K | 30.91K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -273 | 0 | 0 |
| Other Current Liabilities | 1.8M | 4.84M | 11.41M | 6.64M | 5.05M | 111.03K | 4.9M | 0 | 0 | 0 | 0 | 0 | 0 | -27.97K | 0 | 0 | 0 | 55.1K | 12.74K | 12.25K |
| Current Ratio | 2.26x | 0.17x | 0.17x | 0.09x | 0.22x | 0.09x | 0.01x | 0.05x | 0.02x | 0.20x | 0.80x | 1.92x | 2.54x | 3.62x | 6.08x | 8.25x | 24.40x | 1.00x | - | - |
| Quick Ratio | 2.14x | 0.14x | 0.17x | 0.09x | 0.22x | 0.09x | 0.01x | 0.05x | 0.02x | 0.20x | 0.80x | 1.92x | 2.54x | 3.62x | 6.08x | 8.25x | 24.40x | 1.00x | - | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 96.25K | 95.66K | 9.9K | 49.28K | 49.3K | 0 | 0 | 3.85M | 0 | 0 | 0 | 0 | 10.81M | 10.81M | 10.81M | 10.81M | 10.81M | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 96.25K | 95.66K | 9.9K | 49.28K | 49.3K | 0 | 0 | 3.85M | 0 | 0 | 0 | 0 | 10.81M | 10.81M | 10.81M | 10.81M | 10.81M | 0 | 0 | 0 |
| Total Liabilities | 3.25M | 7.69M | 13.87M | 10.61M | 8.92M | 1.69M | 6.57M | 6.24M | 2.63M | 403.33K | 316.32K | 284.36K | 11.17M | 11.12M | 11M | 10.96M | 10.86M | 293.7K | 225.47K | 43.16K |
| Total Debt | 499.21K | 1.38M | 1.38M | 1.83M | 1.71M | 1.27M | 436.28K | 5.36M | 2M | 12.38K | 0 | 0 | 0 | 27.97K | 0 | 0 | 0 | 238.6K | 212.73K | 30.91K |
| Net Debt | -5.36M | 380.87K | -563.49K | 1.62M | 364.02K | 1.26M | -6.17M | 5.36M | 2M | 12.38K | -280 | -125.2K | -315.15K | -497.26K | -533.13K | -579.75K | -618.12K | 238.6K | 212.73K | 30.91K |
| Debt / Equity | 0.13x | - | - | - | - | - | 4.83x | 8.54x | 0.11x | 0.00x | - | - | - | 0.00x | - | - | - | - | 759.74x | 1.98x |
| Debt / EBITDA | - | - | 1.58x | - | - | - | - | - | - | - | - | - | - | 0.01x | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | -0.64x | - | - | - | - | - | - | - | - | -508.95x | - | -0.22x | -2074.43x | - | -2822.47x | - | - | - |
| Interest Coverage | -1.03x | -0.30x | -0.25x | -2.75x | -53.98x | -17.57x | - | -1.89x | -12.46x | -15.84x | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 3.87M | -6.38M | -11.47M | -9.62M | -6.95M | -1.54M | 90.28K | 627.3K | 17.57M | 19.58M | 19.58M | 20.28M | 291.94M | 289.07M | 286.84M | 285.76M | 285.64M | -475 | 280 | 15.59K |
| Equity Growth % | 155.64% | -314.02% | -12801.2% | -1633.03% | -139.58% | -107.87% | -99.54% | -96.91% | -93.98% | -93.23% | -93.17% | -92.9% | 2.21% | 60856138.32% | 99999900% | 1832862.23% | 1589162.33% | - | - | - |
| Book Value per Share | 2.59 | -4.27 | -9.26 | -7.80 | -7.34 | -2.23 | 0.13 | 0.91 | 25.46 | 30.75 | 30.75 | 25.55 | 324.94 | 321.74 | 319.26 | 318.06 | 611.40 | -0.00 | 0.00 | 0.02 |
| Total Shareholders' Equity | 3.87M | -6.38M | -11.47M | -9.62M | -6.95M | -1.54M | 90.28K | 627.3K | 17.57M | 19.58M | 19.58M | 20.28M | 291.94M | 289.07M | 286.84M | 285.76M | 285.64M | -475 | 280 | 15.59K |
| Common Stock | 17 | 353 | 4.95K | 4.95K | 4.89K | 169.99K | 6.6M | 6.53M | 20.14M | 19.9M | 19.64M | 20.02M | 302.2M | 299M | 296.46M | 295.13M | 294.69M | 718 | 646 | 863 |
| Retained Earnings | -30.48M | -27.26M | -22.55M | -20.7M | -18.72M | -2.78M | -15.38M | -14.76M | -13.99M | -11.29M | -10.88M | -10.55M | -10.26M | -9.94M | -9.62M | -9.37M | -9.05M | -25.48K | -24.72K | -9.41K |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |